RESEARCH-USE BIOSIMILAR ANTIBODY
Anrukinzumab
Monoclonal antibody · IgG1
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
TARGETIL13
YMonoclonal antibody
CATALOGSC-BS-763
CATALOG NUMBERSC-BS-763
MOLECULAR WEIGHTApprox. 145.38 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
Anrukinzumab is a recombinant research-use antibody directed against IL13.